Skip to content
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
IFPMA
  • Who We Are
    • IFPMA in Brief
    • Our Governance and Leadership
    • Our Membership
      • Full Members
        • Associations
        • Companies
      • Affiliate Members
    • Our Experts
    • Join Us
  • Topics
  • News Center
    • News Releases
    • Blog
      • Global Health Matters
      • Science Matters
      • DG’s Column
    • Statements
  • Resources
    • Publications
      • News Releases
      • Statements
      • Position Papers
      • Publications
      • External Studies
      • Infographics
      • Event Highlights
    • Multimedia
      • Interviews
      • Videos
      • Slides
    • IFPMA Interactive Platforms
      • IFPMA COVID-19 Hub
      • Global Health Progress
      • 50 Years of Global Health Progress
  • Events
    • Upcoming IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
    • Past IFPMA Events
      • Geneva Pharma Forums
      • Assemblies
      • Other IFPMA Events
      • IFPMA in External Events
      • IFPMA Press Briefings
  • Partners
  • BCR
  • Inventing Medicines and Vaccines
  • Strengthening Regulatory Systems
  • Ethics and Business Integrity
  • Boosting Innovation and Access
  • Tackling Global health challenges
Climate change Economic footprint IP Sustainable innovation Value of innovation

spotlight

Value of innovation

Inventing Medicines and Vaccines
African Medicines Agency Biosimilars Biotherapeutic medicines Falsified medicines Import testing Pharmacovigilance Quality, safety, and efficacy Regulatory conferences Regulatory system strengthening / Harmonization Supply chain The Africa Regulatory Network (ARN) The ARN: Le réseau africain de réglementation pharmaceutique

spotlight

Pharmacovigilance

Strengthening Regulatory Systems
IFPMA Code of Practice (2019) Our Ethos in Action Our Ethos Code eLearning Tool IFPMA Notes for Guidance IFPMA Complaint Operating Procedure How to File a Code Complaint Complaint Submission Form Cases Business Ethics for APEC SMEs Initiative Consensus Framework for Ethical Collaboration

spotlight

IFPMA Code of Practice (2019)

Ethics and Business Integrity
Access to medicines Global Policy Principles on Digital Health Health technology assessment IP Technology Transfer Trade

spotlight

Access to medicines

Boosting Innovation and Access
Ageing Antimicrobial resistance Cancer Child and maternal health COVID-19 Diabetes Ebola Falsified medicines HIV/AIDS Influenza Malaria Mental and neurological disorders Neglected tropical diseases Non-communicable diseases Pandemic Preparedness Public health implications of the implementation of the Nagoya Protocol Rare diseases Supply chain Sustainable development goals Tuberculosis Universal Health Coverage Vaccination confidence Vaccines innovation Vaccines protect communities Vaccines sustainability Value of immunization Viral hepatitis

spotlight

Universal Health Coverage

Tackling Global health challenges
  • Home
  • >
  • Resources
  • >
  • External Studies
  • >
  • ICC principles on creating and nurturing innovation ecosystems for high-tech industries

ICC principles on creating and nurturing innovation ecosystems for high-tech industries

Published on: 04 December 2015

2015-ICC-Innovation-Principles-1

Downloads

» Publication

Resources

Innovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan
Publications

Publications

Innovation for a healthier world: How the research-based vaccine manufacturers are contributing to the Decade of vaccines action plan

Adaptive innovation, intellectual property and public interest
Publications

Publications

Adaptive innovation, intellectual property and public interest

The economic footprint of the pharmaceutical industry
External Studies

External Studies

The economic footprint of the pharmaceutical industry

Assessing the value of biopharmaceutical innovation in key therapy areas in middle-income countries
Publications

Publications

Assessing the value of biopharmaceutical innovation in key therapy areas in middle-income countries

“I am Innovation” (©IFPMA) (Portuguese subtitles)
Videos

Videos

“I am Innovation” (©IFPMA) (Portuguese subtitles)

Biopharmaceutical innovation and legal certainty: the value of legal certainty
Videos

Videos

Biopharmaceutical innovation and legal certainty: the value of legal certainty

Related Blog Entries

Constantly Innovating

Constantly Innovating

Pharma innovation – giving value for value received

Pharma innovation – giving value for value received

Never Stop Advancing – Incremental Innovation

Never Stop Advancing – Incremental Innovation

Related Topics

Sustainable innovation
Economic footprint
Value of innovation

Tags

  • Economic footprint
  • High-Tech industry
  • Innovation ecosystem
  • IP
  • Pharmaceutical Innovation
  • Policy
IFPMA

Chemin des Mines 9
1202 Geneva
Switzerland

+41 22 338 32 00
info@ifpma.org

  • File a Code Complaint
  • Privacy Policy
  • Terms of Use
  • Access to Our Extranet
  • Careers
  • Contact Us
  • IFPMA Twitter
  • IFPMA LinkedIn
  • IFPMA Youtube
  • IFPMA Slideshare
  • IFPMA Flickr
  • IFPMA RSS
Designed and Produced by ACW
^ Back to Top